Trials / Sponsors / UMN Pharma Inc.

UMN Pharma Inc.

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Completed	A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older Influenza, Vaccine	Phase 3	2015-02-01
Completed	Study of ASP7374, Cell-culture-derived Influenza Vaccine Influenza, Vaccine	Phase 3	2013-10-01
Completed	A Study to Evaluate Intramuscular ASP7374 Influenza, Vaccine	Phase 3	2013-10-01
Completed	Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine Influenza	Phase 3	2012-10-01
Completed	A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers Healthy	Phase 2	2011-07-01
Completed	A Study to Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult Volunteers Healthy, Immunogenicity of ASP7374	Phase 1 / Phase 2	2011-05-01
Completed	Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Prime Influenza	Phase 2	2010-10-01
Completed	Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young A Influenza, Virus Diseases	Phase 2	2009-10-01